Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...

For COPD, it’s been tricky to pin ... the third received both the new benralizumab injection and the standard steroid pills. After 28 days, symptoms like coughing and breathlessness had ...

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... now “fully staffed to launch” the new product in the US through a network ...

The drug – which is administered twice-daily using a nebuliser as a chronic maintenance therapy for people with COPD – achieved ... Shares in Verona popped on the news, rising more than ...

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

"Unfortunately, no drug gets rid of asthma completely ... "But it’s appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years," she said.